References
  1. Stasik CJ, Tawfik O. Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation (malignant triton tumor).Arch Pathol Lab Med. 2006 Dec;130(12):1878-81.
  2. McConnell YJ, Giacomantonio CA. Malignant triton tumors-complete surgical resection and adjuvant radiotherapy associated with improved survival. J Surg Oncol. 2012 Jul 1;106(1):51-6.
  3. Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, et al. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Eur J Surg Oncol. 2013 Jan;39(1):46-52.
  4. Yakulis R, Manack L, Murphy Jr AI. Postradiation malignant triton tumor. A case report and review of the literature. Arch pathol Lab Med. 1996 Jun;120(6):541-8.
  5. Ozer E, Erkilic S, Bayazit YA, Mumbuc S, Aydin A, Kanlikama M.Malignant triton tumor of the supraclavicular region arising after radiotherapy. Auris Nasus Larynx. 2002 Oct;29(4):405-7.
  6. Mut M, Cataltepe O, Söylemezoglu F, Akalan N, Ozgen T.Radiation-induced malignant triton tumor associated with severe spinal cord compression. Case report and review of the literature. Neurosurg. 2004 Mar;100(3 Suppl Spine):298-302.
  7. Masson P, Martin JF. Rhabdomyomes des nerfs. Bull Assoc Franc Etude Cancer. 1938;27:751-67.
  8. Woodruff JM, Chernik NL, Smith MC, Millett WB, Foote Jr FW.Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant “Triton” tumors) Cancer. 1973 Aug;32(2):426-39.
  9. Strauss BL, Gutmann DH, Dehner LP, Hirbe A, Zhu X, Marley EF, et al.Molecular analysis of malignant triton tumors. Hum Pathol. 1999 Aug;30(8):984-8.
  10. Victoria L, McCulloch TM, Callaghan EJ, Bauman NM. Malignant triton tumor of the head and neck: a case report and review of the literature. Head Neck. 1999 Oct;21(7):663-70.
  11. Chao MM, Levine JE, Ruiz RE, Kohlmann WK, Bower MA, Petty EM, et al.Malignant triton tumor in a patient with Li-Fraumeni syndrome and a novel TP53 mutation. Pediatr Blood Cancer. 2007 Dec;49(7):1000-4.
  12. Okur FV, Oguz A, Karadeniz C, Citak C, Bayik P, Boyunaga O. Malignant triton tumor of the pelvis in a 2-year-old boy J Pediatr Hematol Oncol. 2006 Mar;28(3):173-6.
  13. Terzic A, Bode B, Gratz KW, Stoeckli SJ. Prognostic factors for the malignant triton tumor of the head and neck. Head Neck. 2009 May;31(5):679-88.
  14. Sönmez K, Türkyilmaz Z, Karabulut R, Kapisiz A, Eser EP, Memis L, et al. A Triton tumor mimicking sacrococcygeal teratoma. Pediatr Surg. 2009 Nov:44(11):e5-8.
  15. Brtko J, Sejnová D, Ondková S, Macejová D. Malignant Triton tumour exhibits a complete expression pattern of nuclear retinoid and rexinoid receptor subtypes. Gen Physiol Biophys. 2009 Dec;28(4):425-7.
  16. Engel EE, Brassesco MS, Valera ET, Nogueira-Barbosa MH, De Almeida Santos Yamashita M, Scrideli CA, et al. Clinico-genetic aspects of a pediatric non-neurofibromatosis type 1 malignant triton tumor with loss of chromosome X. Pediatr Blood Cancer. 2012 Dec 15;59(7):1320-3.
  17. Jaing TH, Chuang CC, Jung SM, Wu CT, Tseng CK, Chen CS.Malignant triton tumor of the cervical spine: report of one case and review of the literature. Pediatr Neonatol. 2015 Feb;56(1):58-61.
  18. Mallah FA, Tanrikulu B, Corapcioglu F, Özek MM. Malignant triton tumor of trigeminal nerve-case report. Childs Nerv Syst. 2018 May;34(5):983-986.
  19. Bian Y, Yongbo X, Xi Z, Zhao D, Wu H, Liu Y. A series of 10 malignant triton tumors in one institution. Medicine (Baltimore) 2009 Sep;98(36):e16797.
  20. Brooks JS, Freeman M, Enterline HT. Malignant triton tumors. Natural history and immunohistochemistry of nine new cases with literature review. Cancer. 1985 Jun 1;55(11)2543-9.
  21. Hennig Y, Löschke S, Katenkamp D, Bartnitzke S, Bullerdiek J.A malignant triton tumor with an umbalanced translocation (1;13)(q10;q10) and an isochromosome (8)(q10) as the sole karyotypic abnormalities. Cancer Ghenet Cytogen. 2000 Apr 1;118(1):80-2.
  22. Kim ST, Kim CW, Han GC, Park C, Jang IH, Cha HE, et al.Malignant triton tumor of the nasal cavity. Head Neck. 2001 Dec;23(12):1075-8.
  23. Lang-Lazdunski L, Pons F, Jancovici R. Malignant “Triton” tumor of the posterior mediastinum: prolonged survival after staged resection. Ann Thorac Surg. 2003 May;75(5):1645-8.
  24. Zisis C, Fragoulis S, Rontogianni D, Stratakos G, Bellenis I.Malignant triton tumour of the anterior mediastinum as incidental finding. Monaldi Arch Chest Dis. 2006 Dec;65(4):222-4.
  25. McComb EN, McComb RD, DeBoer JM, Neff JR, Bridge JA.Cytogenetic analysis of a malignant triton tumor and a malignant peripheral nerve sheat tumor and a review of the literature. Cancer Genet Cytogenet. 1996 Oct 1;91(1):8-12.
  26. Prieto R, Pascual JM, García-Cabezas MA, López-Barea F, Barrios L, González-Llanos F. Low grade malignant triton tumor in the lumbar spine: a rare variant of malignant peripheral nerve sheat tumor with rhabdomyoblastic differentiation. Neuropathology. 2012 Apr;32(2):180-9.
  27. Gong Li, Liu XY, Zhang WD, Han XJ, Yao L, Zhu SJ et al. A rare case of malignant triton tumor in the cerebellopontine angle. Diagn Pathol. 2012 Apr 19;7:43.
  28. Gao L, Song H, Mu k, Wang J, Guo B, Shi B, et al. Primary epididymis malignant triton tumor: case report and review of the literature. Eur J Med Res. 2015 Sep 21;20(1):79.
  29. Bruzzone E, Melloni I, Barra S, Fraternali Orcioni G, Cocito L.A rare case of intracranial malignant triton tumor arising in the middle cranialfossa: a case and review of the literature. Folia Neuropathol. 2018;56(3):229-34.
  30. Konishi N, Hiasa Y, Shimoyama T, Seki A, Mazima M. Malignant triton tumor with metastatic hemangiopericytoma in a patient associated with von Recklinghausen´s disease. Acta Pathol Jpn. 1986 Mar;36(3):459-69.
  31. Haddadin MH, Hawkins AL, Long P, Morsberger LA, Depew D, Epstein JI, et al. Cytogenetic study of malignant triton tumor: a case report. Cancer Genet Cytogenet. 2003 Jul 15;144(2):100-5.
  32. Thoennissen NH, Schliemann C, Brunnberg U, Schmidt E, Staebler A, Stegger L, et al. Chemotherapy in metastatic malignant triton tumor: report on two cases. Oncol Rep. 2007 Oct;18(4):763-7.
  33. Radovanovic D, Vukotic-Maletic V, Stojanovic D, Lalosevic DJ, Likic I, Stojsic Z, et al. Retroperitoneal “Triton” tumor.Hepatogastroenterology. Mar-Apr 2008;55(82-83):527-30.
  34. Koutsopoulos AV, Mantadakis E, Katzilakis N, Lagoudaki ED, de Bree E, Stiakaki E, et al. Long term survival of a patient with a neurofibromatosis type 1 associated retroperitoneal malignant triton tumor after multi-modality treatment. Clin Neuropathol. 2011 Nov-Dec;30(6):333-5.
  35. Li Z, Xiang J, Yan S, Gao F, Zheng S. Malignant triton tumor of the retroperitoneum: a case report and review of the literature.World J Surg Oncol. 2012 May 30;10:96.
  36. Daimaru Y, Hashimoto H, Enjoji M. Malignant ”triton” tumors: a clinicopathologic and immunohistochemical study of nine cases. Hum Pathol. 1984 Aug;15(8):768-78.
  37. Brohl AS, Kahen E, Yoder SJ, Teer JK, Reed DR. The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation. Sci Rep. 2017 Nov 8;7(1):14992.
  38. Peacock J, Pridgeon MG, Tovar EA, Essenburg CJ, Bowman M, Madaj Z, et al. Genomic status of MET potentiates sensitivity to MET and MEK inhibition in NK1-related malignant peripheral nerve sheath tumors. Cancer Res. 2018 Jul 1;78(13):3672-87.
  39. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.